MS PATHS Normative Sub-Study
- Conditions
- Healthy Volunteer
- Registration Number
- NCT02996084
- Lead Sponsor
- Biogen
- Brief Summary
The primary objective of this study is to determine the normative range of brain volume and brain volume change in healthy control (HC) participants whose age, race, and gender distribution is approximately matched to the age, race, and gender distribution of patients with Multiple Sclerosis (MS) enrolled in Study 888MS001. The secondary objective is to use the results of the primary endpoint to ensure consistency of brain volume measurements across MS PATHS centers.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 246
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Brain volume Every 12 months up to 3 years Measured by using magnetic resonance imaging (MRI) scans
Brain volume change Every 12 months up to 3 years Measured by using MRI scans
- Secondary Outcome Measures
Name Time Method Development of models to calibrate brain volume measurements between centers, if necessary Up to 3 years Measured by using MRI scans
Trial Locations
- Locations (6)
Johns Hopkins University
πΊπΈBaltimore, Maryland, United States
The Cleveland Clinic Foundation
πΊπΈCleveland, Ohio, United States
Multiple Sclerosis Centre of Catalonia (Cemcat) Vall d'Hebron Hospital
πͺπΈBarcelona, Spain
University Hospital Carl Gustav Carus Dresden
π©πͺDresden, Germany
Washington University
πΊπΈSaint Louis, Missouri, United States
University of Rochester Medical Center
πΊπΈRochester, New York, United States